![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 09, 2006 1:40:54 PM
I was talking about DNAG's drugs, not their tests. Provide proof that they have been working on them for years. You're confusing the two. Intentionally, IMO.
"DNAPrint genomics Obtains Exclusive License From Beth Israel Deaconess Medical Center, Harvard Affiliate, to Develop New Anemia Drug
Tuesday April 5, 8:30 am ET "
"DNAPRINT GENOMICS LICENSES RITALIN-LIKE COMPOUNDS TARGETING
ENHANCED TREATMENT OF DRUG ADDICTION AND ATTENTION N DEFICIT
SARASOTA, Fla., Oct. 25, 2005"
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM